The short answer: urolithin A has several small human trials, but the headline claims rest on secondary results and every trial we read is tied to Amazentis, which makes the Mitopure ingredient. In 66 older adults the primary endpoints (6-minute walk and muscle ATP) did not significantly improve; in middle-aged adults muscle strength rose about 12% but the primary endpoint, peak power, did not. At the 1,000 mg a day used in two trials it costs about $198 a month as Timeline’s Mitopure bought once ($178 on monthly delivery), $138 as Omre and $90 as Mt. Angel (brand pages, 29 Sept 2026). Talk to your doctor before starting.
What the trials show
Grades follow the rubric; overall grade: Emerging.
What the trials do not show: any effect on lifespan, disease risk or long-term safety. Nothing here compares urolithin A with exercise, which is the established way to build muscle and fitness.
Cost per month at the 1,000 mg/day trial dose
Two trials above used 1,000 mg a day (Liu 2022 and Denk 2025). This is a price comparison, not a recommendation of any amount. Prices from brand pages on 29 Sept 2026, before tax, shipping and subscription discounts; our arithmetic.
Timeline’s page data lists $99 for a one-time purchase and $89 for monthly delivery (the plan is named 1-month supply delivered monthly); Omre’s own page claims Timeline costs $125 a bottle, which does not match Timeline’s page. Omre also lists $65.55 on subscription. Check the checkout price. The Cell Rep Med abstract does not state its doses, so we price only the two trials that do. For comparison, creatine has far more evidence for muscle, at a fraction of the price; none of the urolithin A trials we read was independent of the maker. The full cost per study dose table covers 12 compounds.
Where it fits
See urolithin A in the graded supplement ladder, and the strength training protocol for the established way to build muscle. The complete stack shows sequencing.
The testing statements in the table range from NSF certification to unnamed labs; third-party testing explained.
Method note
Researched from PubMed abstract records and three brand pages, checked 29 Sept 2026. Abstracts only; grades are our judgement using the published rubric. We did not test any product. Longevity Intel earns a commission on some links. General information, not medical advice.